Status:
COMPLETED
TDM of Asparaginase in ALL2008
Lead Sponsor:
Aarhus University Hospital
Conditions:
Acute Lymphoblastic Leukemia
Eligibility:
All Genders
1-45 years
Brief Summary
Asparaginase is a cornerstone in the treatment of ALL. In most contemporary protocols like in NOPHO ALL2008 prolonged asparaginase treatment has been implemented. Publish data from NOPHO ALL2008 show...
Eligibility Criteria
Inclusion
- ALL treated on the NOPHO ALL2008 protocol, age 1-45 years.
Exclusion
- No samples sent
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2024
Estimated Enrollment :
765 Patients enrolled
Trial Details
Trial ID
NCT04843514
Start Date
April 1 2021
End Date
January 31 2024
Last Update
February 6 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital, Denmark
Aarhus N, Denmark, 8200
2
Aarhus University Hospital
Aarhus N, Denmark, 8200